News -

A New Generation of Cell-Biosensors targeting Cancer

Read the latest article in IPT (Innovations in Pharmaceutical Technology) about the new generation cell-biosensors that enables studies in a more relevant cellular environment to better understand drug-cell interactions for development of new pharmaceuticals. A model like this using bio-sensors could significantly reduce the costs and time-scales involved in the development of the next generation of therapeutics.

Related links

Topics

  • Medical research

Categories

  • ipt
  • miriam dwek
  • teodor aastrup
  • attana cell 200
  • label free
  • quartz crystal microbalance
  • university of westminster

Related media

Related content

  • Biosensor- Attana Cell 200, label free, real time kinetics on cells

    Revolutionary Swedish invention can potentially improve drug development! Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.

  • Find out: Why bridge the existing gap between biochemical and cell based assays?

    One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.

  • Attana in Swedish Life Sciences

    Swedes are well known to be innovative and building successful global companies and international brands. In Swedish Life Sciences many of the Swedish companies representing the entire health care spectrum are compiled and presented, there among Attana AB.

Enter your email address to follow Attana AB

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Attana AB.

Okay